Skip to main content
. 2015 May 25;5(5):e008312. doi: 10.1136/bmjopen-2015-008312

Table 1.

Timeline of trial interventions

Schedule
Treatment day (TD)
Time point (T)
T0 (Screening, baseline and prediagnosis tests) T1 (Treatment and discharge)
T2 3M T3 6M T4 12M Withdrawal
TD 1* TD 2 TD 3 TD 4 TD 5 Rescue therapy† Discharge
Screening with diagnostic algorithm and core investigations including physical examination X
Patient information and informed consent X
Eligibility form X
Registration form X
Prediagnosis tests—for example, MRI and AQP4 X
Randomisation X
Biobank samples X X
ASIA Impairment Score (A-E) X X X X P X
ASIA Motor and Sensory Score X X X X S X
Neurostatus scoring (Kurtzke functional systems and EDSS) X X X S X
8–12 years EQ-5D-Y X X S X
≥13 years EQ-5D-5L X X S X
≥13 years SCI QoL Basic data set X S X
CSRI X S X
≥13 years SCI Bladder T X
≥13 years SCI Bowel T X
5–7 years Peds QL T X
2–4 years Peds QL T X
Treatment form X
Concomitant medications X X X X
Discharge form X
Rescue therapy form (if needed)† X
Relapse form (at any time point if needed)† X X X X
Adverse events‡ X X X X X
Study Status Form X X X
Withdrawal form (at any time point)† X

*Treatment day 1: IVIG treatment (if applicable) to start on the same day as randomisation. Steroids may be started up to 5 days prior to randomisation.

†Rescue therapy, relapse and withdrawal forms may only be necessary for a small subset of patients.

‡Adverse events will be collected throughout the study.

ASIA, American Spinal Injury Association; AQP4, aquaporin-4; CSRI, Client Service Receipt Inventory; EDSS, expanded disability status scale; Peds QL, Pediatric Quality of Life Inventory; P, primary outcome measure; S, secondary outcome measure; SCI, Spinal Cord Injury; T, tertiary outcome measure.